Accordingly, YAP overexpressing mice are more susceptible to cancer development in response to DSS treatment, due to crosstalk of YAP with β-catenin and STAT3 signaling which activate transcriptional programs fueling stemness and proliferation [30, 144]. The gene discussed is YAP1; the disease is cancer.